Sabra Health Care REIT, Inc.
SBRANASDAQReal Estate● Active
$17.92
$-0.55(-2.95%)
Market Cap$4.5B
P/E Ratio—
52W High$21.28
52W Low$17.17
Sabra Health Care REIT, Inc. (SBRA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SBRA · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
$0.39
Est. $0.17 · +133.9%
Revenue
$0.22B
Est. $0.21B · +6.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 9-Quarter EPS Beat Streak
SBRA reports quarterly as a NASDAQ-listed REIT - Healthcare Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.40
Rev. $5.46B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.40
Rev. Est.$5.46B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 3, 2026 | $0.17 | — | — | — | $0.22B | — |
| ▲ Q2 FY2026 | Apr 29, 2026 | $0.17 | $0.39 | +133.9% | $0.22B | $0.21B | +6.0% |
| ▲ Q1 FY2026 | Feb 12, 2026 | $0.17 | $0.38 | +123.5% | $0.21B | $0.20B | +7.0% |
| — Q4 FY2025 | Nov 5, 2025 | $0.38 | $0.38 | +0.0% | $0.19B | $0.20B | -5.9% |
| ▲ Q3 FY2025 | Aug 4, 2025 | $0.37 | $0.38 | +2.7% | $0.19B | $0.19B | +0.9% |
| ▲ Q2 FY2025 | May 5, 2025 | $0.36 | $0.37 | +2.8% | $0.18B | $0.18B | +0.6% |
| — Q1 FY2025 | Feb 19, 2025 | $0.36 | $0.36 | +0.0% | $0.18B | $0.18B | +2.4% |
| ▲ Q4 FY2024 | Oct 31, 2024 | $0.36 | $0.37 | +2.8% | $0.18B | $0.18B | +1.4% |
Q3 FY2026
Aug 3, 2026
EPS Actual
—
EPS Est.
$0.17
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026Beat
EPS Actual
$0.39
EPS Est.
$0.17
EPS Surpr.
+133.9%
Revenue
$0.22B
Q1 FY2026
Feb 12, 2026Beat
EPS Actual
$0.38
EPS Est.
$0.17
EPS Surpr.
+123.5%
Revenue
$0.21B
Q4 FY2025
Nov 5, 2025
EPS Actual
$0.38
EPS Est.
$0.38
EPS Surpr.
+0.0%
Revenue
$0.19B
Q3 FY2025
Aug 4, 2025Beat
EPS Actual
$0.38
EPS Est.
$0.37
EPS Surpr.
+2.7%
Revenue
$0.19B
Q2 FY2025
May 5, 2025Beat
EPS Actual
$0.37
EPS Est.
$0.36
EPS Surpr.
+2.8%
Revenue
$0.18B
Q1 FY2025
Feb 19, 2025
EPS Actual
$0.36
EPS Est.
$0.36
EPS Surpr.
+0.0%
Revenue
$0.18B
Q4 FY2024
Oct 31, 2024Beat
EPS Actual
$0.37
EPS Est.
$0.36
EPS Surpr.
+2.8%
Revenue
$0.18B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.20 | $0.22 | $0.23 | 1 |
| Q3 FY2028 | $0.20 | $0.22 | $0.23 | 1 |
| Q2 FY2028 | $0.20 | $0.21 | $0.23 | 1 |
| Q1 FY2028 | $0.19 | $0.20 | $0.21 | 1 |
| Q4 FY2027 | $0.18 | $0.19 | $0.21 | 1 |
| Q3 FY2027 | $0.18 | $0.19 | $0.20 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q3 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q2 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q1 FY2028 | $0.2B | $0.2B | $0.2B | 1 |
| Q4 FY2027 | $0.2B | $0.2B | $0.3B | 1 |
| Q3 FY2027 | $0.2B | $0.2B | $0.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +133.9% | $20.51 | $20.35 | -0.78% |
| ▲ Q1 FY2026 | Feb 12, 2026 | +123.5% | $19.60 | $20.25 | +3.32% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +0.0% | $17.98 | $18.20 | +1.22% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +2.7% | $18.29 | $18.41 | +0.66% |
| ▲ Q2 FY2025 | May 5, 2025 | +2.8% | $17.42 | $17.28 | -0.80% |
| ▲ Q1 FY2025 | Feb 19, 2025 | +0.0% | $16.46 | $16.55 | +0.55% |
| ▲ Q4 FY2024 | Oct 31, 2024 | +2.8% | $19.58 | $19.40 | -0.92% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +2.9% | $16.48 | $16.66 | +1.09% |
Q2 FY2026-0.78%
Report Date
Apr 29, 2026
EPS Beat/Miss
+133.9%
Price Before
$20.51
Price After
$20.35
Q1 FY2026+3.32%
Report Date
Feb 12, 2026
EPS Beat/Miss
+123.5%
Price Before
$19.60
Price After
$20.25
Q4 FY2025+1.22%
Report Date
Nov 5, 2025
EPS Beat/Miss
+0.0%
Price Before
$17.98
Price After
$18.20
Q3 FY2025+0.66%
Report Date
Aug 4, 2025
EPS Beat/Miss
+2.7%
Price Before
$18.29
Price After
$18.41
Q2 FY2025-0.80%
Report Date
May 5, 2025
EPS Beat/Miss
+2.8%
Price Before
$17.42
Price After
$17.28
Q1 FY2025+0.55%
Report Date
Feb 19, 2025
EPS Beat/Miss
+0.0%
Price Before
$16.46
Price After
$16.55
Q4 FY2024-0.92%
Report Date
Oct 31, 2024
EPS Beat/Miss
+2.8%
Price Before
$19.58
Price After
$19.40
Q3 FY2024+1.09%
Report Date
Aug 7, 2024
EPS Beat/Miss
+2.9%
Price Before
$16.48
Price After
$16.66
Avg Beat Reaction+0.54%
Beat Rate8 / 8 quarters
Largest Move+3.32% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SBRA ends December
Sabra Health Care REIT, Inc. (SBRA) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $0.39 — beating the analyst consensus of $0.17 by +133.9%. SBRA has beaten EPS estimates for 9 consecutive quarters. The next SBRA earnings date is expected around September 1, 2026.
Each quarter, investors track SBRA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SBRA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SBRA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SBRA earnings · 5 questionsSabra Health Care REIT, Inc.'s next earnings report is expected around September 1, 2026. SBRA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SBRA historically reports after market close (AMC).
SBRA earnings datewhen is SBRA earningsSBRA next earnings datewhen does SBRA report earningsSBRA earnings calendar
▸ Source: FMP · Sabra Health Care REIT, Inc. SEC filings · US GAAP · Sabra Health Care REIT, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026